6533b7d2fe1ef96bd125f6ed
RESEARCH PRODUCT
Quality of Life in Individuals Affected by Arnold Chiari Malformation: Comparison and Validation of a Measurement Instrument.
María Luisa Ballestar-tarínLucia Mari-avarguesMiriam Vazquez-seoaneCarlos Saus-ortegaAntonio Martínez-sabaterMaria Del Carmen Casal-angulosubject
AdultMalemedicine.medical_specialtyPsychometricsEndocrinology Diabetes and MetabolismHealth StatusContext (language use)Linguistic validation030218 nuclear medicine & medical imagingCorrelation03 medical and health sciences0302 clinical medicineQuality of lifeCronbach's alphaCost of IllnessPredictive Value of TestsSickness Impact ProfileSurveys and QuestionnairesImmunology and AllergyMedicineHumansInternal validityReliability (statistics)business.industryfungiReproducibility of ResultsMiddle AgedTranslatingSyringomyeliaArnold-Chiari MalformationSpainScale (social sciences)Physical therapyQuality of LifeFemalebusiness030217 neurology & neurosurgerydescription
BACKGROUND Introduction. Arnold Chiari Malformation (ACM) type I is a pathology whose symptomatology has repercussions for the quality of life of those affected by it. Quality-of-life measurement instruments can allow the severity of the impact of Chiari type I malformation on patients' lives to be monitored. The Chiari Symptom Profile (CSP) is a valid and reliable instrument designed for this purpose. The aim of the study was to adapt the CSP to Spanish and to explore the reliability and validity of this construct in the context of Spanish-speaking patients with ACM. METHODS The English CSP instrument has a good internal validity and consistency. We used a standardized procedure for the linguistic validation of the translated scale. For the psychometric validation, we recruited 215 individuals with ACM and calculated the Cronbach's alpha for the sample. The construct was validated by analyzing the age, sex, and presence of syringomyelia, as well as by correlating the results with the sickness impact profile 30 (SIP-30) questionnaire, which can also evaluate quality of life in this type of patient. RESULTS The Spanish version of the CSP has good internal consistency and validity (Cronbach's alpha of 0.90); age, sex, and the presence of syringomyelia does not significantly affect the quality of life of patients with ACM. There was a direct and significant correlation between the Spanish CSP and the validated SIP-30 questionnaire results (p < 0.05). Further analysis showed a positive correlation for the physical and psychological scopes of the CSP and SIP-30 questionnaires, but not for their functional and social scopes. CONCLUSION This version of the CSP is a valid and reliable instrument for measuring quality of life in patients with ACM in the Spanish context.
year | journal | country | edition | language |
---|---|---|---|---|
2017-07-13 | Endocrine, metabolicimmune disorders drug targets |